Korsana Biosciences, Inc.
corporate_fare Company Profile
Korsana Biosciences, Inc. (NASDAQ:KRSA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for KRSA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 4 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for KRSA spans 10-Q, 8-K, PRE 14A.
Recent high-impact activity:
- Korsana 10-Q: $456.2M Cash Funds Operations Into 2029 After Cyclerion Merger
- Korsana Posts $46.4M Q3 Loss, $456M Cash Funds Operations Into 2029
- Korsana Posts $46.4M Q3 Loss, $456.2M Cash Funds Operations Into 2029
- Korsana Resubmits Cayman Islands Redomestication After Failed Vote, Proposes Classified Board and Exclusive Forum
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 167,367 shares in KRSA as of the October 30, 2026 settlement, a 603.1% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 72.2% of KRSA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.